Larry E. Douglass

1.0k total citations
11 papers, 490 citations indexed

About

Larry E. Douglass is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Larry E. Douglass has authored 11 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Larry E. Douglass's work include Genetic factors in colorectal cancer (3 papers), TGF-β signaling in diseases (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Larry E. Douglass is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), TGF-β signaling in diseases (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Larry E. Douglass collaborates with scholars based in United States and Vietnam. Larry E. Douglass's co-authors include Julia H. Carter, James A. Deddens, Jeremy R. Graff, Bruce M. Colligan, Jackson O. Pemberton, Joanne T. Hom, Mark S. Marshall, David R. Weber, Bruce W. Konicek and Stephen H. Parsons and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Larry E. Douglass

11 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry E. Douglass United States 7 366 139 72 58 46 11 490
Corinna Kosnopfel Germany 13 308 0.8× 111 0.8× 69 1.0× 46 0.8× 28 0.6× 23 448
Junfang Ji China 8 362 1.0× 107 0.8× 113 1.6× 17 0.3× 46 1.0× 11 478
Zhenqing Feng China 12 201 0.5× 179 1.3× 48 0.7× 55 0.9× 38 0.8× 30 408
Jeannette Gogel Germany 7 371 1.0× 149 1.1× 46 0.6× 26 0.4× 21 0.5× 8 471
Boaz Nachmias Israel 11 451 1.2× 185 1.3× 87 1.2× 56 1.0× 47 1.0× 57 697
Wenjun Bie United States 12 406 1.1× 230 1.7× 66 0.9× 35 0.6× 44 1.0× 18 527
Aïda Ghoul France 8 254 0.7× 85 0.6× 58 0.8× 31 0.5× 33 0.7× 10 379
Joana Carvalho United Kingdom 11 356 1.0× 207 1.5× 105 1.5× 21 0.4× 33 0.7× 13 552
Natalie Ludyga Germany 7 288 0.8× 139 1.0× 156 2.2× 40 0.7× 37 0.8× 8 406
Harrys K.C. Jacob United States 12 368 1.0× 163 1.2× 61 0.8× 18 0.3× 63 1.4× 20 539

Countries citing papers authored by Larry E. Douglass

Since Specialization
Citations

This map shows the geographic impact of Larry E. Douglass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Douglass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Douglass more than expected).

Fields of papers citing papers by Larry E. Douglass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Douglass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Douglass. The network helps show where Larry E. Douglass may publish in the future.

Co-authorship network of co-authors of Larry E. Douglass

This figure shows the co-authorship network connecting the top 25 collaborators of Larry E. Douglass. A scholar is included among the top collaborators of Larry E. Douglass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry E. Douglass. Larry E. Douglass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Carter, Julia H., et al.. (2018). Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer. British Journal of Cancer. 119(4). 462–470. 23 indexed citations
2.
Nasir, Aejaz, Beverly L. Falcón, Dan Wang, et al.. (2018). Vascular and tumor cell expression of VEGFR2 and molecular subtyping: An innovative biomarker approach in bladder cancer.. Journal of Clinical Oncology. 36(6_suppl). 497–497. 1 indexed citations
3.
Carter, Julia H., James A. Deddens, Bruce M. Colligan, et al.. (2016). Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma. British Journal of Cancer. 114(4). 444–453. 37 indexed citations
4.
Fajardo, Alexandra M., et al.. (2015). Abstract 1024: Targeting PAK1 activity in breast cancer: Inhibition of cell growth, survival, motility, and signaling. Cancer Research. 75(15_Supplement). 1024–1024. 1 indexed citations
5.
Carter, Julia H., et al.. (2013). Abstract 22: Overexpression of PAK 1 is a favorable prognostic biomarker in malignant melanoma.. Cancer Research. 73(8_Supplement). 22–22. 1 indexed citations
6.
Graff, Jeremy R., Bruce W. Konicek, Rebecca L. Lynch, et al.. (2009). eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival. Cancer Research. 69(9). 3866–3873. 156 indexed citations
7.
Chen, Taiping, Chad R. Jackson, Andrew J. Link, et al.. (2006). Int7G24A Variant of Transforming Growth Factor-β Receptor Type I Is Associated with Invasive Breast Cancer. Clinical Cancer Research. 12(2). 392–397. 38 indexed citations
8.
Graff, Jeremy R., Stephen H. Parsons, Jana A. Lewis, et al.. (2006). 580 POSTER Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressig tumor-induced angiogenesis and reducing growth of human cancer xenografts. European Journal of Cancer Supplements. 4(12). 176–176. 5 indexed citations
9.
Chen, Taiping, Chad R. Jackson, Ben de Lacy Costello, et al.. (2004). An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. International Journal of Cancer. 112(3). 420–425. 35 indexed citations
10.
Carter, Julia H., Larry E. Douglass, James A. Deddens, et al.. (2004). Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis. Clinical Cancer Research. 10(10). 3448–3456. 148 indexed citations
11.
Weber, David R., et al.. (1969). Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam. The American Journal of Medicine. 46(2). 234–244. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinna Kosnopfel Breakdown of academic impact, for papers by Junfang Ji Breakdown of academic impact, for papers by Zhenqing Feng Breakdown of academic impact, for papers by Jeannette Gogel Breakdown of academic impact, for papers by Boaz Nachmias Breakdown of academic impact, for papers by Wenjun Bie Breakdown of academic impact, for papers by Aïda Ghoul Breakdown of academic impact, for papers by Joana Carvalho Breakdown of academic impact, for papers by Natalie Ludyga Breakdown of academic impact, for papers by Harrys K.C. Jacob
Rankless by CCL
2026